Skip to main content
Premium Trial:

Request an Annual Quote

TriLink Biotech Names 'ResearchRewards' Recipient

Premium

TriLink Biotechnologies said this week that it has awarded Tony Yan, an associate professor of chemistry at Brock University, an award under its "ResearchRewards" program.

Yan will use TriLink's CleanAmp PCR reagents, nucleoside triphosphates, and oligonucleotides in his research on the regulation of nucleic acid hybridization and binding by azobenzene analogues.

"Azobenzene and analogues undergo light-driven geometrical changes and have therefore found applications in systems where such geometrical changes can be taken advantage of," Yan said in a statement. "The ResearchRewards from TriLink will allow us to further explore azobenzene derivatives in the spatiotemporal regulations of events involving nucleic acids."

TriLink's ResearchRewards program, which began in 2002, is designed to help researchers offset the cost of nucleic acid-based products by providing them with complimentary reagents. The company has so far supported more than 30 projects, including research into nucleotide selectivity of error-prone RNA viral polymerase, PCR primer design for undergraduate teaching and research, and CleanAMP primer for detecting mRNA expression and DNA repair of cross-linked DNA.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.